221
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Potential New Approaches for Children's Inhalation Risk Assessment

, , , Jr., , , & show all
Pages 208-217 | Published online: 20 Dec 2007

REFERENCES

  • Baird, S. J. S., Cohen, J. T., Graham, J. D., Shlyakhter, A. I., and Evans, J. S., 1996. Noncancer risk assessment: a probabilistic alternative to current practice, Hum. Ecol. Risk Assess. 2 (1996), pp. 78–99.
  • Bakke, S., Baste, V., and Gulsvik, A., 1991. Bronchial responsiveness in a Norwegian community, Am. Rev. Respir. Dis. 143 (1991), pp. 317–322.
  • Balmes, J. R., Aris, R. M., Chen, L. L., Scannell, C., Tager, I. B., Finkbeiner, W., Christian, D., Keller, T., Hearne, P. Q., Ferrando, R., and Welch, B., 1997. "Airway inflammation and responsiveness to ozone in normal and asthmatic subjects". In: Effects of ozone on normal and potentially sensitive subjects. Cambridge, MA: Health Effects Institute; 1997. pp. 81–99, Research Report Number 78.
  • http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=160003 Last accessed 19Dec2006. , Barton, H., Cogliano, J., Firestone, M. P., Flowers, L., Setzer, R. W., Valcovic, L., and Woodruff, T. 2005. Supplemental guidance for assessing susceptibility from early-life exposure to carcinogens. EPA/630/R-03/003F. Risk Assessment Forum. Washington, DC: U.S. EPA..
  • Clewell, R. A., Merrill, E. A., Yu, K. O., Mahle, D. A., Sterner, T. R., Fisher, J. W., and Gearhart, J. M., 2003. Predicting neonatal perchlorate dose and inhibition of iodide uptake in the rat during lactation using physiologically-based pharmacokinetic modeling, Toxicol. Sci. 74 (2003), pp. 416–436.
  • http://ehp.niehs.nih.gov/members/2003/6182/6182.html, Daston, G., Faustman, E., Ginsberg, G., Fenner-Crisp, P., Olin, S., Sonawane, B.R., Bruckner, J., Breslin, W., and McLaughlin, T. J. 2004. A framework for assessing risks to children from exposure to environmental agents. Environ. Health Perspecdt. 112:238–256..
  • Dorne, J. L. C. M., and Renwick, A. G., 2005. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans, Toxicol. Sci. 86 (2005), pp. 20–26.
  • Dorne, J. L. C. M., Walton, K., and Renwick, A. G., 2001. Uncertainty factors for chemical risk assessment: human variability in the pharmacokinetics of CYP1A2 probe substrates, Food Chem. Toxicol. 39 (2001), pp. 681–696, .
  • Evans, J. S., and Baird, S. J. S., 1998. Accounting for missing data in noncancer risk assessment, Hum. Ecol. Risk Assess. 4 (1998), pp. 291–317.
  • Evelo, C. T. A., Oostendorp, J. G. M., ten Berge, W. F., and Borm, P. J. A., 1993. Physiologically based toxicokinetic modeling of 1,3-butadiene lung metabolism in mice becomes more important at low doses, Environ. Health Perspect. 101 (1993), pp. 496–502.
  • http://www.epa.gov/fedrgstr/eo/eo13045.htm, Executive Order 13045. 1997. Protection of children from environmental health risks and safety risks. Fed. Reg. 62(78):19883–19888..
  • Gargas, M. L., Burgess, R. J., Voisard, D. E., Cason, G. H., and Andersen, M. E., 1989. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues, Toxicol. Appl. Pharmacol. 98 (1989), pp. 87–99.
  • Georgieva, A. V., Kimbell, J. S., and Schlosser, P. M., 2003. A distributed-parameter model for formaldehyde uptake and disposition in the rat nasal lining, Inhal. Toxicol. 15 (2003), pp. 1435–1463.
  • Ginsberg, G. L., Foos, B. P., and Firesetone, M. P., 2005a. Review and analysis of inhalation dosimetry methods for application to children's risk assessment, J. Toxicol. Environ. Health A 68 (2005a), pp. 573–615.
  • Ginsberg, G., Hattis, D., Russ, A., and Sonawane, B., 2005b. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in the elderly, Environ. Health Perspect. 113 (2005b), pp. 1243–1249.
  • Ginsberg, G., Hattis, D., Sonawane, B., Russ, A., Banati, P., Kozlak, M., Smolenski, S., and Goble, R., 2002. Evaluation of child/adult pharmacokinetic differences form a database derived from the therapeutic drug literature, Toxicol. Sci. 66 (2002), pp. 185–200.
  • http://ehp.niehs.nih.gov/members/2003/6013/6013.html, Ginsberg, G.I., Slikker, W. Jr., Bruckner, J., and Sonawane, B. 2004. Incorporating children's toxicokinetics into a risk framework. Environ. Health Perspect. 112:272–283..
  • Haddad, S., Beliveau, M., Tardif, R., and Krishnan, K., 2001. A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures, Toxicol. Sci. 63 (2001), pp. 125–131.
  • Hanania, N. A., Tarlo, S. M., Silverman, F., Urch, B., Senathirajah, N., Zamel, N., and Corey, P., 1998. Effect of exposure to low levels of ozone on the response to inhaled allergen in allergic asthmatic patients, Chest 114 (1998), pp. 752–756.
  • Hattis, D., 2003. "The conception of variability in risk analyses—Developments since 1980". In: McDaniels, T., and Small, M., eds. Risk analysis and society in the 21st century: An interdisciplinary characterization of the field. Cambridge, MA: Cambridge University Press; 2003. pp. 15–45.
  • Hattis, D., 2007. Distributional analyses for children's inhalation risk assessments, J. Toxicol. Environ. Health A 71 (2007), pp. 218–226.
  • Hattis, D., Baird, S., and Goble, R., 2002. A straw man proposal for a quantitative definition of the RfD, Drug Chem. Toxicol. 25 (2002), pp. 403–436.
  • Hattis, D., Banati, P., Goble, R., and Burmaster, D., 1999. Human interindividual variability in parameters related to health risks, Risk Anal. 19 (1999), pp. 705–720.
  • Hattis, D., and Burmaster, D. E., 1994. Assessment of variability and uncertainty distributions for practical risk analyses, Risk Anal. 14 (1994), pp. 713–730.
  • Hattis, D., Ginsberg, G, Sonawane, B., Smolenski, S., Russ, A., Kozlak, M., and Goble, R., 2003. Differences in pharmacokinetics between children and adults. II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling, Risk Anal. 23 (2003), pp. 117–142.
  • Hattis, D., Goble, R., and Chu, M., 2005. Age-related differences in susceptibility to carcinogenesis. II. Approaches for application and uncertainty analyses for individual genetically acting carcinogens, Environ. Health Perspect. 113 (2005), pp. 509–516.
  • Hattis, D., Goble, R., Russ, A., Chu, M, and Ericson, J., 2004. Age-related differences in susceptibility to carcinogenesis—A quantitative analysis of empirical animal bioassay data, Environ. Health Perspect. 112 (2004), pp. 1152–1158.
  • http://www2.clarku.edu/faculty/dhattis Last accessed 19Dec2006. , Hattis, D., and Lynch, M. K. 2006. Interspecies differences and human interindividual variability in tissue-level pharmacokinetic parameters. Task 3—Final report—Description and analyses of the databases. Report by Clark University to the U.S. Environmental Protection Agency under Purchase Order No. EP05W002147..
  • Hattis, D., and Lynch, M. K., 2007. "Empirically observed distributions of pharmacokinetic and pharmacodynamic variability in humans—Implications for the derivation of single point component uncertainty factors providing equivalent protection as existing RfDs". In: Lipscomb, J. C., and Ohanian, E. V., eds. Toxicokinetics in risk assessment. New York: Marcel Dekker; 2007. pp. 69–93.
  • Hattis, D., Russ, A., Goble, R., Banati, P., and Chu, M., 2001. Human interindividual variability in susceptibility to airborne particles, Risk Anal. 21 (2001), pp. 585–599.
  • Hattis, D., and Russ, A., 2004. Role of dosimetric scaling and species extrapolation in evaluating risks across life stages. II. Pharmacokinetic dosimetric considerations in old age. Washington, DC: U. S. EPA; 2004, Final report to the U.S. Environmental Protection Agency under RFQ no. DC-03-0000.
  • International Life Sciences Institute, 2003. Workshop to develop a framework for assessing risks to children from exposures to environmental agents. Washington, DC: ILSI Press; 2003, ILSI, Risk Science Institute.
  • Kimbell, J. S., Subramaniam, R. P., Gross, E. A., Schlosser, P. M., and Morgan, K. T., 2001a. Dosimetry modeling of inhaled formaldehyde: Comparisons of local flux predictions in the rat, monkey, and human nasal passages, Toxicol. Sci. 64 (2001a), pp. 100–110.
  • Kimbell, J. S., Overton, J. H., Subramaniam, R. P., Schlosser, P. M., Morgan, K. T., Conolly, R. B., and Miller, F. J., 2001b. Dosimetry modeling of inhaled formaldehyde: Binning nasal flux predictions for quantitative risk assessment, Toxicol. Sci. 64 (2001b), pp. 111–121.
  • Makri, A., Goveia, M., Balbus, J., and Parkin, B., 2004. Children's susceptibility to chemicals: A review by developmental stage, J. Toxicol. Environ. Health B 6 (2004), pp. 417–435.
  • McConnell, E. E., 1992. "Comparative response in carcinogenesis bioassay as a function of age at first exposure". In: Guzelian, P., Henry, C. J., and Olin, S. S., eds. Similarities and difference between children and adults: Implications for risk assessment. Washington, DC: ILSI Press; 1992. pp. 66–78.
  • http://www.nap.edu/catalog/2126.html, National Research Council. 1993. Pesticides in the diets of infants and children. National Research Council. Washington, DC: National Academy Press..
  • O'Connor, G., Sparrow, D., Taylor, D., Segal, M., and Weiss, S., 1987. Analysis of dose-response curves to methacholine: An approach suitable for population studies, Am. Rev. Respir. Dis. 136 (1987), pp. 1412–1417.
  • www.calepa.cahwnet.gov/oehha, OEHHA. 1996. Technical support document for exposure assessment and stochastic analysis. Oakland, CA: California EPA..
  • http://ehp.niehs.nih.gov/members/2003/6183/6183.html, Olin, S. S., and Sonawane, B.R. 2003. Workshop to develop a framework for assessing risks to children from exposure to environmental agents. Environ. Health Perspect. 111:1524–1526..
  • Paoletti, P., Carrozzi, L., Viegi, G., Modena, P., Ballerin, L., Di Pede, F., Grado, L., Baldacci, S., Pedreschi, M., Vellutini, M., Paggiaro, P., Mammini, U., Fabbri, L., and Giuntini, C., 1995. Distribution of bronchial responsiveness in a general population: Effect of sex, age, smoking, and level of pulmonary function, Am. J. Respir. Crit. Care Med. 151 (1995), pp. 1770–1777.
  • Price, K., Haddad, S., and Krishnan, K., 2003. Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children, J. Toxicol. Environ. Health A 66 (2003), pp. 417–433.
  • Renwick, A. G., 1998. Toxicokinetics in infants and children in relation to the ADI and TDI, Food Addit. Contam. 15 (Suppl) (1998), pp. 17–35.
  • Rhomberg, L. R., and Wolff, S. K., 1998. Empirical scaling of single oral lethal doses across mammalian species based on a large database, Risk Anal. 18 (1998), pp. 741–753.
  • Sarangapani, R., Gentry, P.R., Covington, T.R., Teeguarden, J.G., and Clewell, H.J., 2003. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors, Inhal. Toxicol. 15 (2003), pp. 987–1016.
  • Sarangapani, R., Teeguarden, J.G., Cruzan, G., Clewell, H., and Andersen, M.E., 2002. Physiologically based pharmacokinetic modeling of styrene and styrene oxide respiratory-tract dosimetry in rodents and humans, Inhal. Toxicol. 14 (2002), pp. 789–834.
  • Sears, M., Jones, D. T., Holdaway, M. D., Hewitt, C. J., Flannery, E. M., Herbison, G. P., and Silva, P. A., 1986. Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children, Thorax 41 (1986), pp. 283–289.
  • Shlyakhter, A. I., 1994. An improved framework for uncertainty analysis: accounting for unsuspected errors, Risk Anal. 14 (1994), pp. 441–447, .
  • Tashkin, D. P., Altose, M. D., Connett, J. E., Kanner, R. E., Lee, W. W., and Wise, R. A., 1996. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med. 153 (1996), pp. 1802–1811.
  • http://www.epa.gov/opppsps1/fqpa/, U.S. 104th Congress. 1996a. Food Quality Protection Act (FQPA). P.L. 104–170. U.S. 104th Congress..
  • http://www.epa.gov/safewater/sdwa/text.html, U.S. 104th Congress. 1996b. Safe Drinking Water Act (SDWA) Amendments. P.L. 104–182. U.S. 104th Congress..
  • http://www.epa.gov/ncea/raf/pdfs/devtox.pdf, U.S. Environmental Protection Agency. 1991. Guidelines for developmental toxicity risk assessment. Fed. Reg. 56(234):63798–63826. Washington, DC: U.S. EPA..
  • http://www.epa.gov/osa/spc/htm/memohlth.htm, U.S. Environmental Protection Agency. 1995. Policy on evaluating health risks to children. U.S. Environmental Protection Agency, Office of the Administrator, Washington, DC..
  • http/cfpub.epa.gov/ncea/raf/recordisplay.cfm?deid=2838, U.S. Environmental Protection Agency. 1996a. Guidelines for reproductive toxicity risk assessment. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC. 630/R-96/0009.
  • U.S. Environmental Protection Agency, 1996b. Comparison of the effects of chemicals with combined perinatal and adult exposure vs adult only exposure in carcinogenesis bioassays. Washington, DC: U. S. EPA; 1996b.
  • http://epa.gov/osa/spc/htm/cumrisk2.htm, U.S. Environmental Protection Agency. 1997. Guidance on cumulative risk assessment. Part 1: Planning and scoping. Office of the Administrator, Washington, DC..
  • http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=4555, U.S. Environmental Protection Agency. 1998a. Guidelines for neurotoxicity risk assessment. Fed. Reg. 63(93):26926–26954. Washington, DC: U.S. EPA..
  • http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=36512, U.S. Environmental Protection Agency. 1998b. Guidelines for ecological risk assessment. Fed. Reg. 63(93):26846–26924. Washington, DC: U.S. EPA..
  • http://www.epa.gov/ncea/pdfs/strat4resrch.pdf, U.S. Environmental Protection Agency. 2000d. Strategy for research on environmental risks to children. U.S. Environmental Protection Agency, Office of Research and Development, Washington, D.C. EPA/600/R-00/068..
  • http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=36528, U.S. Environmental Protection Agency. 2002a. Child-specific exposure factor handbook (Interim report). U.S. Environmental Protection Agency, Office of Research and Development, National Center for Environmental Assessment, Washington, DC. EPA/600/P/00/002B.
  • http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=36836, U.S. Environmental Protection Agency. 2002b. A review of the reference dose and reference concentration processes. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC. EPA/630/P-02/002F..
  • http://www.epa.gov/oppfead1/trac/science/determ.pdf, U.S. Environmental Protection Agency. 2002c. Determination of the appropriate FQPA safety factor(s) in tolerance assessment. U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC..
  • http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=429113, U.S. Environmental Protection Agency. 2003. Guidance on selecting the appropriate age groups for assessing childhood exposures to environmental contaminants (External review draft). U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC. EPA/630/P-03/003A..
  • http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=439797, U.S. Environmental Protection Agency. 2005a. Guidelines for carcinogen risk assessment. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC. EPA/630/P-R-03/001B.003.
  • http://cfpuboaspub.epa.gov/ncea/raf/recordisplay.cfm?deid=116283eims/eimscomm.getfile?p_download_id=36766, U.S. Environmental Protection Agency. 2005b. Supplemental guidance for assessing cancer susceptibility from early-life exposure to carcinogens. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC. EPA/630600/R-03/003F..
  • http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=456258, U.S. Environmental Protection Agency. 2005c. Guidance on selecting age groups for monitoring and assessing childhood exposures to environmental contaminants. EPA/630/P-03/003F. Washington, DC: U.S. EPA..
  • http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=56747, U.S. Environmental Protection Agency. 2006. Child-specific exposure factors handbook 2006 (External review draft). EPA/600/R-06/096A. Washington, DC: U.S. EPA.
  • Willems, B. A. T., Melnick, R. L., Kohn, M. C., and Portier, C. J., 2001. A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and mice, Toxicol. Appl. Pharmacol. 176 (2001), pp. 81–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.